Recent mouse breast cancer model studies suggest that carcinoma cell-derived GM-CSF acts to promote an immunosuppressive TME through paracrine regulation of Arginase-1 in the myeloid cell population, which includes macrophages and fibroblasts [62]. This evidence concerns the gene CSF2 and breast carcinoma.